Platelet Aggregation Following Defibrination with Ancrod

Summary

In vitro platelet aggregation was studied in dogs following defibrination with Ancrod. There was marked inhibition of aggregation immediately after defibrination. A gradual return toward normal aggregation was observed over the 96 hours study period, but aggregation was still abnormal at 96 hours after defibrination. There was an inverse and highly significant correlation between aggregation and fibrin degradation product level. Fibrinogen was not measurable after defibrination for the entire study period. Aggregation was thus independent of fibrinogen concentration in this study.

• References

• 1 Ashford A, Ross J. W, Southgate P. 1968; Pharmacology and toxicology of a defibrinating substance from malayan pit viper venom. Lancet 486.
• 2 Bell W. R, Pitney W. R, Goodwin J. F. 1968; Therapeutic defibrination in the treatment of thrombotic disease. Lancet 490.
• 3 Bell W. R, Bolton G, Pitney W. R. 1968; The effect of arvin on blood coagulation factors. British Journal of Haematology 15: 589.
• 4 Brecher G, Cronkite E. P. 1950; Morphology and Enumeration of Human Blood Platelets. Journal of Applied Physiology 3: 365.
• 5 Brown C. H, Bell W. R, Shreiner D. P, Jackson D. P. 1972; Effects of arvin on blood platelets. In vitro and in vivo studies. Journal of Laboratory and Clinical Medicine 79: 758.
• 6 Browse N. L. 1974. Vein surgery during defibrination. In: Martin M, Schoop W. (ed), Aktuelle Probleme in der Angiologie: 26, Defibrinierung mit thrombinähnlichen Schlangengiftenzymen. Hans Huber, Bern; Stuttgart, Wien.:
• 7 Clauss A. 1957; Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Hematologia 17: 237.
• 8 Davey M. G, Lüscher E. F. 1967; Actions of thrombin and other coagulent and protelytic enzymes on blood platelets. Nature 216: 857.
• 9 Esnouf M. P, Tunnah G. W. 1967; The isolation and properties of the thrombin-like activity from ancistrodon rhodostoma venom. British Journal of Haematology 13: 581.
• 10 Garvey M. B, Black J. M. 1972; The detection of fibrinogen/fibrin degradation products by means of a new antibody coated latex particle. Journal of Clinical Pathology 25: 680.
• 11 Harker L. A. 1974. Hemostasis Manual. F. A. Davis Co.; Philadelphia: 68.
• 12 Prentice C. R. M, Hassanein A. A, Turpe A. G. G, McNicol G. P, Douglas A. S. 1969; Changes in platelet behavior during Arvin Therapy. Lancet 644.
• 13 Reid H. A, Chan K. E. 1968; The paradox in therapeutic defibrination. Lancet 485.
• 14 Sharp A. A, Warren B. A, Paxton A. M, Allington M. J. 1968; Anticoagulation therapy with a purified fraction of malayan pit viper venom. Lancet 493.
• 15 Smith R. T, Tsao C. 1973; Fibrin degradation products in the postoperative period. American Journal of Clinical Pathology 60: 644.